Thu, Sep 18, 2014, 1:47 AM EDT - U.S. Markets open in 7 hrs 43 mins

Recent

% | $
Quotes you view appear here for quick access.

Inovio Pharmaceuticals, Inc. Message Board

  • the.bio.fan@gmail.com the.bio.fan Aug 11, 2013 9:43 PM Flag

    Lots of scared rabbits here tonight looking for comfort!

    LOL! Priceless!

    Sentiment: Hold

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Scared of what?

      Jul 24, 2013 -Inovio Pharmaceuticals' Potent hTERT DNA Cancer Vaccine Shows Potential to Reduce Tumors and Prevent Tumor Recurrence
      Mice and monkey study demonstrates robust and broad immune responses; T-cells 18-fold greater than next best peer technology induce tumor-killing function and increase rate of survival

      Jul 18, 2013 -Synthetically Optimized HIF-1 Alpha DNA Delivered with Inovio's Electroporation Technology Provides Significant Therapeutic Effects for Peripheral Arterial Disease in Animal Model
      New application of CELLECTRA® electroporation technology dramatically enhances ability of DNA therapy to stimulate blood vessel growth and recovery from debilitation caused by blocked arteries of the legs.

      Jul 10, 2013 -Inovio's CELLECTRA® Electroporation Delivery Technology Powers Durable, Best-in-Class T-Cell Responses from HIV Vaccine in Human Study
      Next-generation HIV vaccine achieves seven-fold increase (7% to 52%) in response rate of CD8 T-cells when delivered with electroporation; robust CD4 or CD8 T-cell responses observed in 89% of subjects

      Jul 8, 2013- Inovio Pharmaceuticals' Universal H7N9 DNA Vaccine Protects 100% of Vaccinated Animals in Challenge Study
      For the first time a vaccine shields animals from sickness and death against the newly emergent H7N9 flu virus; vaccine generates significant levels of T-cells and protective antibodies

      Jun 20, 2013- Inovio Pharmaceuticals to Present at OneMedForumNY 2013 Investor Conference

      Jun 14, 2013 -Inovio's Universal H7N9 DNA Vaccine Generates First Protective Antibody Responses Against Virulent H7N9 Virus in 100% of Vaccinated Animals
      Universal H7N9 vaccine generates protective HAI antibodies against unmatched influenza strain in 100% of tested animals; also shows how quickly Inovio can respond to a pandemic threat

      May 14, 2013 -Inovio Pharmaceuticals DNA Vaccine Against Ebola and Marburg Filoviruses Provides Complete Protection in Preclinical Challenge Study
      Polyvalent Vaccine Design Stim

 
INO
10.41-0.09(-0.86%)Sep 17 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.